Search

Search Constraints

You searched for: Author/Creator Defer, Gilles

Search Results

1. Descriptive analysis of the French NS-Park registry: Towards a nation-wide Parkinson's disease cohort?. (July 2019)

3. Effects of Age and Disease Duration on Excess Mortality in Patients With Multiple Sclerosis From a French Nationwide Cohort. (27th July 2021)

4. Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab. Issue 4 (July 2021)

8. Transverse Myelitis Following SARS‐CoV‐2 Vaccination: A Pharmacoepidemiological Study in the World Health Organization's Database. Issue 6 (23rd September 2022)

9. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022)

10. Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial. Issue 6 (11th November 2013)